XPO Logistics expands Board of Directors 20 September 2017

XPO Logistics has announced the appointment of AnnaMaria DeSalva to its Board of Directors, effective immediately. DeSalva has joined the Board as an independent Director of the Company. Her appointment expands XPO's board to eight directors, six of whom are independent directors.

AnnaMaria brings more than 20 years of executive experience to the Board, with an emphasis on helping global companies excel at brand development and cultural integration. Her appointment furthers XPO's commitment to strong corporate governance and a diversity that reflects its strategy and scale.

DeSalva is Global Chief Communications Officer for DuPont, where she is responsible for corporate brand strategy and stakeholder communications, most recently related to the US$150.0 billion merger with Dow. Prior to joining DuPont in 2014, she served as Head of Corporate Affairs for Biopharmaceutical Innovation at Pfizer, a role that included the integration of Pfizer's US$68.0 billion acquisition of Wyeth. Earlier, she served as an advisor to the US Food and Drug Administration, and led the global healthcare practice of Hill & Knowlton. For Bristol-Myers Squibb, she led global public affairs for the oncology business with a focus on European market development, and served as the Director of the Bristol-Myers Squibb Foundation.

In addition to XPO Logistics, she serves on the board of governors of Argonne National Laboratory, a science and engineering research laboratory of the US Department of Energy, and is a member of its compensation and nominating committees; as well as the Boards of Directors of the non-profit Project Sunshine and the William & Mary Alumni Association.